Metformin, a drug traditionally prescribed for diabetes but recently used in clinical settings as a cancer treatment, shows “great promise” but can have negative consequences in the treatment of some cancer types, researchers at the University of Waterloo in Canada said Feb. 28.
Read the full post on Becker's Hospital Review - Healthcare News
